INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 42h ago
HOUSE PTR2h ago
SEC 13F2h ago
ROBINHOOD CHAIN2h ago
Corporate insider
MC

Mazumdar Claire

Director, Chief Executive OfficerCIK 0002034671

EDGAR filingsOpen in network
Disclosed transactions14
Buys / sells0 / 2
Max Insider Score30
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
0
MC
Mazumdar ClaireDirector, Chief Executive Officer
BCAXBicara Therapeutics Inc.
Option exercise · 10b5-1 plan
M—
15.0K sh
Apr 20, 2026Apr 20, 2026
traded Apr 20, 2026
+0dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Bicara Therapeutics Inc.Director, Chief Executive Officer · Nov 25, 2025
0
MC
Mazumdar ClaireDirector, Chief Executive Officer
BCAXBicara Therapeutics Inc.
Option exercise · 10b5-1 plan
M
$57K
15.0K sh
Apr 20, 2026
Apr 20, 2026
traded Apr 20, 2026
+0d
SEC FORM 4

Evidence

12
MC
Mazumdar ClaireDirector, Chief Executive Officer
BCAXBicara Therapeutics Inc.
Open-market sale · 10b5-1 plan
SELL$354K
15.0K sh
Apr 20, 2026Apr 20, 2026
traded Apr 20, 2026
+0dSEC FORM 4

Evidence

0
MC
Mazumdar ClaireDirector, Chief Executive Officer
BCAXBicara Therapeutics Inc.
Option exercise · 10b5-1 plan
M—
8,226 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC FORM 4

Evidence

0
MC
Mazumdar ClaireDirector, Chief Executive Officer
BCAXBicara Therapeutics Inc.
Option exercise · 10b5-1 plan
M—
7,454 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC FORM 4

Evidence

0
MC
Mazumdar ClaireDirector, Chief Executive Officer
BCAXBicara Therapeutics Inc.
Option exercise · 10b5-1 plan
M—
7,080 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC FORM 4

Evidence

0
MC
Mazumdar ClaireDirector, Chief Executive Officer
BCAXBicara Therapeutics Inc.
Option exercise · 10b5-1 plan
M$36K
8,226 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC FORM 4

Evidence

0
MC
Mazumdar ClaireDirector, Chief Executive Officer
BCAXBicara Therapeutics Inc.
Option exercise · 10b5-1 plan
M$28K
7,454 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC FORM 4

Evidence

0
MC
Mazumdar ClaireDirector, Chief Executive Officer
BCAXBicara Therapeutics Inc.
Option exercise · 10b5-1 plan
M$39K
7,080 sh
Apr 16, 2026Apr 20, 2026
traded Apr 16, 2026
+4dSEC FORM 4

Evidence

12
MC
Mazumdar ClaireDirector, Chief Executive Officer
BCAXBicara Therapeutics Inc.
Option exercise
M$161K
29.5K sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC FORM 4

Evidence

9
MC
Mazumdar ClaireDirector, Chief Executive Officer
BCAXBicara Therapeutics Inc.
Option exercise
M—
29.5K sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC FORM 4

Evidence

6
MC
Mazumdar ClaireDirector, Chief Executive Officer
BCAXBicara Therapeutics Inc.
Option exercise · 10b5-1 plan
M$156K
41.2K sh
Nov 24, 2025Nov 25, 2025
traded Nov 24, 2025
+1dSEC FORM 4

Evidence

30
MC
Mazumdar ClaireDirector, Chief Executive Officer
BCAXBicara Therapeutics Inc.
Open-market sale · 10b5-1 plan
SELL$776K
41.2K sh
Nov 24, 2025Nov 25, 2025
traded Nov 24, 2025
+1dSEC FORM 4

Evidence

7
MC
Mazumdar ClaireDirector, Chief Executive Officer
BCAXBicara Therapeutics Inc.
Option exercise · 10b5-1 plan
M—
41.2K sh
Nov 24, 2025Nov 25, 2025
traded Nov 24, 2025
+1dSEC FORM 4

Evidence